Evonik Q3 2023 Earnings Presentation

Evonik reported sequential earnings improvement in Q3 2023 with adjusted EBITDA of €485m, driven by self-help measures and positive momentum in Animal Nutrition. The company confirmed FY2023 EBITDA guidance of €1.6-1.8bn and expects strong cash generation with FCF reaching 40% conversion by year-end.